NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/03/2024
Back to search
Official data from USPTO
MYELOID TARGETING PLATFORM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MYELOID TARGETING PLATFORM
ST13
US500000098086316Class
42
Filing
98086316
Registration
7591913
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
12/03/2024
Trademark type
Word
Nice classes
42
Filing date
07/14/2023
Registration date
12/03/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/03/2024
Last transaction
12/03/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
06/03/2024
First use in commerce
06/03/2024
Drawing code
4
Owner type
03
Owner location
Tokyo, JP
Examiner
MANOR, THOMAS
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
UNITED IMMUNITY, CO., LTD.
Representatives
Boris Umansky LADAS & PARRY LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical research services in the field of cancer; scientific research; medical research; medical and scientific research in the field of drug discovery; pharmaceutical research services; medical and scientific research information in the field of drug discovery; DNA screening for scientific research purposes; laboratory research services relating to pharmaceuticals; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals; cell culture services for scientific and research purposesfor others; providing medical and scientific research information; consulting services in the field of pharmaceutical research and development; DNA analysis services for scientific research purposes; scientific research consulting
Publications
History of USPTO decisions and trademark events.
21 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
12/03/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
11/12/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
11/12/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/12/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
11/12/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/12/2024
IUAA
USE AMENDMENT ACCEPTED
10/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/09/2024
ALIE
ASSIGNED TO LIE
10/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/24/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
06/24/2024
IUAF
USE AMENDMENT FILED
06/24/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
06/24/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/25/2024
GNRT
NON-FINAL ACTION E-MAILED
03/25/2024
CNRT
NON-FINAL ACTION WRITTEN
03/25/2024
DOCK
ASSIGNED TO EXAMINER
03/21/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/14/2023
NWAP
NEW APPLICATION ENTERED
07/18/2023
Continuous trademark protection
Get notified about every new filing that threatens MYELOID TARGETING PLATFORM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.